Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Owlstone Medical — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
Watch the 2-minute tour · with sound

Owlstone Medical Enters into a Research Collaboration Agreement with the FDA

Sep 30, 2024over 1 year ago

Contract Type

agreement

CambridgeBiotechnologyHealth Care

Description

Owlstone Medical has entered into a five-year Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL) to develop methods for the confident identification of individual chemicals in the complex mixture of breath. The goal of the collaboration is to develop Regulatory Science Tools (RSTs) for the identification of Volatile Organic Compounds (VOCs) in complex mixtures.

Company Information

Company

Owlstone Medical

Location

Cambridge, England, United Kingdom

About

Owlstone Medical is on a mission is to save 100,000 lives and $1.5bn in healthcare costs. We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease. Our products and services are for research use only. Not for use in diagnostic procedures.

Predictive Intelligence
Strategic

ML-powered predictions for Owlstone Medical's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months